What is ESPR's dilution risk score?

ESPR has a latest available DilutionScore record of 48/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ESPR, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ESPR?

DilutionWatch tracks 25 SEC filing types for ESPR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ESPR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ESPR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ESPR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ESPR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ESPR Dilution Risk Score: 48/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

0

📊 Float Risk

12

⚠️ Warrant Exposure

50

🔄 Convertible Debt

35

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 15%

🔄 Reverse Split model est. 15%

• 52-week low $0.85 has breached $1

📜 Warrant Exercise model 15%

• Warrant overhang: 14.4% of shares outstanding

🔁 Convertible Conversion model 15%

• Convertible debt present: 12.1% potential dilution

🔔 Track ESPR — Get forecast alerts →

Market Data

Market Cap$805.76M

Shares Outstanding257.43M

Float255.18M

Cash$156.16M

Debt$292.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 29.7% shares (2026Q1 vs prior)

208 institutional holders · 203.70M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 20.87M shares

#2 BlackRock, Inc. 17.85M shares

#3 WASATCH ADVISORS LP 15.77M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-31

xbrl XBRL WARRANT 2025-12-31

8-K 8K EVENT 2026-04-02

4 INSIDER TRANSACTION 2026-03-18

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ESPR Dilution Snapshot

Esperion Therapeutics, Inc. (ESPR) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 37.0M.
Recent SEC activity tracked for ESPR: 8-K on 2026-04-02; xbrl on 2026-03-31; 4 on 2026-03-18.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.